Publicaciones en las que colabora con Juan García de Lomas Barrionuevo (29)

2012

  1. The undiagnosed cases of Clostridium difficile infection in a whole nation: Where is the problem?

    Clinical Microbiology and Infection, Vol. 18, Núm. 7

2010

  1. Antimicrobial resistance among respiratory pathogens in Spain: Latest data and changes over 11 years (1996-1997 to 2006-2007)

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 7, pp. 2953-2959

2008

  1. Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277

2007

  1. Impact of amoxicillin, associated or not with clavulanic acid, on pharyngeal colonization and selection of Streptococcus pneumoniae resistance in children under 5 years of age

    European Journal of Pediatrics, Vol. 166, Núm. 5, pp. 467-471

2006

  1. Alterations of the penicillin-binding proteins and murM alleles of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 57, Núm. 2, pp. 224-229

  2. Combinations of PBPs and MurM protein variants in early and contemporary high-level penicillin-resistant Streptococcus pneumoniae isolates in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 57, Núm. 5, pp. 983-986

  3. Invasive pneumococcal disease among children in a health district of Barcelona: Early impact of pneumococcal conjugate vaccine

    Clinical Microbiology and Infection, Vol. 12, Núm. 9, pp. 867-872

2005

  1. Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 5, pp. 1965-1972

  2. New mutations and horizontal transfer of rpoB among rifampin-resistant Streptococcus pneumoniae from four Spanish hospitals

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 6, pp. 2237-2245

  3. Nosocomial bloodstream infections caused by Streptococcus pneumoniae

    Clinical Microbiology and Infection, Vol. 11, Núm. 11, pp. 919-924

  4. Sensibilidad in vitro a los antibióticos y serotipos más frecuentes de Streptococcus pneumoniae. Estudio multicéntrico

    Revista Espanola de Quimioterapia, Vol. 18, Núm. 1, pp. 45-51

2004

  1. Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae Clones, Spain

    Emerging Infectious Diseases, Vol. 10, Núm. 10, pp. 1751-1759

  2. Spectrum of antibiotic resistance of the Spain14-5 Streptococcus pneumoniae clone over a 22 year period

    Journal of Antimicrobial Chemotherapy, Vol. 53, Núm. 4, pp. 620-625

2003

  1. Evolution of penicillin and erythromycin co-resistance in Streptococcus pneumoniae in Spain

    International Journal of Antimicrobial Agents, Vol. 22, Núm. 5, pp. 541-544

  2. Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model

    Journal of Antimicrobial Chemotherapy, Vol. 52, Núm. 6, pp. 967-973

  3. The epidemiology of antibiotic resistance in Streptococcus pneumoniae and the clinical relevance of resistance to cephalosporins, macrolides and quinolones

    International Journal of Antimicrobial Agents

2002

  1. Activities of six different quinolones against clinical respiratory isolates of streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 8, pp. 2665-2667

  2. Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]

    Journal of Antimicrobial Chemotherapy

  3. In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 3, pp. 892-895

2001

  1. Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: Results of a 1-year (1998-1999) multicenter surveillance study in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 45, Núm. 12, pp. 3334-3340